Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference80 articles.
1. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein;Aertgeerts;J. Biol. Chem.,2011
2. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth;Agus;Cancer Cell,2002
3. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics;Arteaga;Cancer Cell,2014
4. Protocols for molecular modeling with Rosetta3 and RosettaScripts;Bender;Biochemistry,2016
5. Activating HER2 mutations in HER2 gene amplification negative breast cancer;Bose;Cancer Discov.,2013
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10
2. Mechanisms of acquired resistance to HER2-Positive breast cancer therapies induced by HER3: A comprehensive review;European Journal of Pharmacology;2024-08
3. A Comprehensive Review of HER2 in Cancer Biology and Therapeutics;Genes;2024-07-11
4. Analysis on the pathogenesis and treatment progress of NRG1 fusion-positive non-small cell lung cancer;Frontiers in Oncology;2024-06-18
5. HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review;Medicine;2024-06-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3